高钾血症的人群流行病学:心脏与肾脏长期健康结局
基于英国Grampian地区302,630名有血液检测的成人队列,高钾血症年发病率为0.96/100人年,三分之二发生在社区。高钾血症与全因死亡、心脏事件及肾衰竭长期风险独立相关,且eGFR≥60者关联更强。
要点
- 高钾血症年人群发病率为0.96/100人年,三分之二发生于社区。
- 高钾血症与全因死亡、心脏事件及肾衰竭风险独立相关。
- eGFR≥60者高钾血症与不良结局关联更强(交互P<0.001)。
核心结论
- 高钾血症在一般人群负担显著,与长期死亡、心脏事件及肾衰竭风险独立相关。
研究设计与样本
- 基于英国Grampian地区468,594名成人(2012-2014年)的人群队列,其中302,630名至少一次血检者随访至2019年。
主要发现
- 高钾血症年发病率为0.96/100人年,2012、2013、2014年分别占至少一次血检者的2.3%、2.1%、1.9%。
- 高钾血症者并发急性肾损伤(AKI)的可能性高20倍,eGFR<30 mL/min/1.73 m2的可能性高17倍。
- eGFR≥60 mL/min/1.73 m2者高钾血症 vs 无高钾血症的调整HR:死亡2.3(95%CI 2.2-2.5),心脏事件1.8(95%CI 1.6-1.9),肾衰竭17.0(95%CI 9.3-31.1)。
- eGFR<30 mL/min/1.73 m2者上述调整HR分别为死亡1.5(95%CI 1.3-1.6)、心脏事件1.4(95%CI 1.2-1.6)、肾衰竭2.0(95%CI 1.5-2.8)。
关键数值与推荐
- 高钾血症定义为血清钾≥5.5 mmol/L。
- 年龄每增加10岁,高钾血症发生率增加2倍。
- eGFR≥60与<30 mL/min/1.73 m2组间交互作用P<0.001。
临床怎么用
- 社区高钾血症常见,需关注长期心脏和肾脏结局。
- 肾功能正常者高钾血症的肾脏不良结局风险尤其突出。
局限性
- 观察性设计限制因果推断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: The population burden and long-term implications of hyperkalemia have not been comprehensively studied. We studied how often and where hyperkalemia occurs as well as its independent association with survival and long-term cardiac and kidney health. STUDY DESIGN: Population-based cohort study of adult residents of Grampian, United Kingdom. SETTING & PARTICIPANTS: Among the 468,594 adult residents (2012-2014), 302,630 people with at least 1 blood test were followed until 2019. EXPOSURE: Hyperkalemia was defined as serum potassium ≥ 5.5 mmol/L. Adjustment for comorbidities, demographics, measures of acute and chronic kidney function, and medications prescribed before measurement of serum potassium. OUTCOME: All-cause mortality, cardiac events, and kidney failure. ANALYTICAL APPROACH: Description of the annual incidence of hyperkalemia and the characteristics associated with its occurrence, and adjusted Cox proportional hazards (PH) analysis to evaluate the independent long-term association of hyperkalemia with all-cause mortality among people who survived ≥90 days after blood testing. Cause-specific PH models were fit to evaluate the association of hyperkalemia with cardiac events/death, noncardiac death, and kidney failure. Effect modification by level of estimated glomerular filtration rate (eGFR) at the time of blood testing was explored. RESULTS: The annual population incidence of hyperkalemia was 0.96 per 100 person-years. This represented 2.3%, 2.1%, and 1.9% of people with at least one blood test in 2012, 2013, and 2014, respectively. Two-thirds of episodes of hyperkalemia occurred in the community. The hyperkalemia rate was 2-fold higher for each 10-year greater age. Those with hyperkalemia were 20 times more likely to have concurrent acute kidney injury (AKI), and 17 times more likely to have an eGFR of <30 mL/min/1.73 m2. Throughout 5 years of follow-up evaluation (2,483,452 person-years), hyperkalemia was associated with poorer health outcomes. This association held across all levels of kidney function and was irrespective of concurrent AKI, but was stronger among those with a baseline eGFR of ≥60 mL/min/1.73 m2 (P for interaction < 0.001). The adjusted HRs (hyperkalemia vs no hyperkalemia) for people with eGFR ≥60 mL/min/1.73 m2 and eGFR <30 mL/min/1.73 m2 were 2.3 (95% CI, 2.2-2.5) and 1.5 (95% CI, 1.3-1.6) for mortality; 1.8 (95% CI, 1.6-1.9) and 1.4 (95% CI, 1.2-1.6) for cardiac events; and 17.0 (95% CI, 9.3-31.1) and 2.0 (95% CI, 1.5-2.8) for kidney failure, respectively. LIMITATIONS: The observational nature of this study limits evaluation of causal relationships. CONCLUSIONS: There is a substantial burden of hyperkalemia in the general population. Hyperkalemia is associated with poorer long-term health outcomes, especially kidney outcomes, that are independent of other established risk factors.
引用
- Mclean A, Nath M, Sawhney S, et al. Population Epidemiology of Hyperkalemia: Cardiac and Kidney Long-term Health Outcomes. Am J Kidney Dis. 2021. PMID: 34419518. doi:10.1053/j.ajkd.2021.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。